Ebitda 更改
Gilead Sciences USD 2.73B 579M 2023-12
RedHill Biopharma USD -3813000 93.38M 2023-06
Supernus Pharmaceuticals USD 40.87M 10.87M 2023-12



Intra Cellular Therapies - 当前值,历史数据,预测,统计,图表和经济日历 - May 2024.